Online citations, reference lists, and bibliographies.
← Back to Search

Understanding Micrometastatic Disease And Anoikis Resistance In Ewing Family Of Tumors And Osteosarcoma.

S. Strauss, T. Ng, A. Mendoza-Naranjo, J. Whelan, P. Sorensen
Published 2010 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Detection of micrometastatic tumor cells in the bone marrow or peripheral blood of patients with Ewing family of tumors (EFTs) and osteosarcoma has been shown to correlate with poor outcome. Although one of the aims of chemotherapy is eradication of micrometastatic disease, these cells vary phenotypically from primary tumor cells and appear to be more resistant to chemotherapy. As a barrier to metastasis, cells normally undergo a form of cell death termed anoikis after they lose contact with the extracellular matrix or neighboring cells. Tumor cells that acquire malignant potential have developed mechanisms to resist anoikis and thereby survive after detachment from their primary site and while traveling through the circulation. Investigating mechanisms of resistance to anoikis, therefore, provides a valuable model to investigate regulation of micrometastatic disease. This review focuses on the current understanding of the mechanisms involved in mediating cell survival and resistance to anoikis in EFTs and osteosarcoma and discusses future studies that may help to identify novel therapeutics targeted at micrometastatic disease.
This paper references
10.1002/(SICI)1097-0142(20000515)88:10<2252::AID-CNCR8>3.0.CO;2-Q
Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma
W. Janni (2000)
10.1038/sj.onc.1208091
Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis
L. Wei (2004)
10.1128/MCB.25.12.5282-5291.2005
G1/S Cell Cycle Arrest Provides Anoikis Resistance through Erk-Mediated Bim Suppression
N. L. Collins (2005)
10.1038/sj.onc.1205989
Src activation regulates anoikis in human colon tumor cell lines
T. Windham (2002)
10.1038/nm1716
Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation
M. Hilton (2008)
10.1016/j.canlet.2008.05.029
Anoikis resistance and tumor metastasis.
Craig D. Simpson (2008)
10.1200/JCO.2008.16.5720
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
M. Paulussen (2008)
10.1002/ijc.23825
Review: Biological relevance of disseminated tumor cells in cancer patients
S. Riethdorf (2008)
10.1007/s10555-008-9160-9
Caveolin-1 in tumor progression: the good, the bad and the ugly
J. Goetz (2008)
10.1091/MBC.4.9.953
The extracellular matrix as a cell survival factor.
J. Meredith (1993)
10.1056/NEJMOA020890
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
H. Grier (2003)
10.1016/0955-0674(94)90127-9
Membrane-actin microfilament connections: an increasing diversity of players related to band 4.1.
M. Arpin (1994)
10.1038/nm982
The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis
C. Khanna (2004)
10.1684/bdc.2009.0915
Targeting IGF-1R in the treatment of sarcomas: past, present and future.
S. Kim (2009)
10.1038/nrg2101
Genetic determinants of cancer metastasis
D. Nguyen (2007)
10.1038/nature08268
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Z. Schafer (2009)
10.1128/MCB.26.5.1754-1769.2006
The Insulin-Like Growth Factor I Receptor Is Required for Akt Activation and Suppression of Anoikis in Cells Transformed by the ETV6-NTRK3 Chimeric Tyrosine Kinase
M. J. Martin (2006)
10.1002/(SICI)1097-4652(199809)176:3<648::AID-JCP22>3.0.CO;2-U
Insulin‐like growth factor‐I‐mediated survival from Anoikis: Role of cell aggregation and focal adhesion kinase
B. Valentinis (1998)
10.1038/359162A0
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
O. Delattre (1992)
Apoptotic signaling during initiation of detachment-induced apoptosis ("anoikis") of primary human intestinal epithelial cells.
J. Grossmann (2001)
10.1200/JCO.1992.10.1.5
Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
P. Meyers (1992)
10.1038/ng.438
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4
T. Prickett (2009)
10.1023/A:1023772912750
Src family kinases in tumor progression and metastasis
J. Summy (2004)
10.1200/JCO.2007.13.6523
Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.
K. Pachmann (2008)
10.1158/0008-5472.CAN-06-0927
Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells.
O. Tirado (2006)
10.1111/j.1600-0463.2008.01059.x
New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?  
P. Goss (2008)
10.1158/1078-0432.CCR-07-1992
Critical Role of Notch Signaling in Osteosarcoma Invasion and Metastasis
P. Zhang (2008)
10.1016/0959-8049(93)90183-G
Insulin-like growth factor-I-dependent growth and in vitro chemosensitivity of Ewing's sarcoma and peripheral primitive neuroectodermal tumour cell lines.
S. Hofbauer (1993)
10.1038/sj.onc.1203711
The integrin-linked kinase (ILK) suppresses anoikis
S. Attwell (2000)
10.1038/onc.2009.206
Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin
X. Wan (2009)
10.1016/J.BCP.2006.08.011
Focal adhesion kinase: a potential target in cancer therapy.
Maroesja J. van Nimwegen (2007)
10.1038/sj.onc.1201792
Prolonged cell survival enhances peritoneal dissemination of gastric cancer cells
A. Yawata (1998)
10.1002/ijc.11399
Overexpression of BAD preferentially augments anoikis
M. Idogawa (2003)
Metastasis-related genes in prostate cancer.
C. Bangma (1999)
10.1056/NEJMOA050434
A pooled analysis of bone marrow micrometastasis in breast cancer.
Stephan Braun (2005)
10.1016/j.bcp.2008.07.023
Anoikis: a necessary death program for anchorage-dependent cells.
P. Chiarugi (2008)
10.1200/JCO.2000.18.1.80
Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients.
S. Braun (2000)
10.1016/S0002-9440(10)64442-2
Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation.
C. Ho (2002)
p21WAF1 regulates anchorage-independent growth of HCT116 colon carcinoma cells via E-cadherin expression.
S. Mueller (2000)
10.1038/onc.2009.61
TrkA overexpression enhances growth and metastasis of breast cancer cells
C. Lagadec (2009)
10.1093/hmg/ddp057
Notch signaling contributes to the pathogenesis of human osteosarcomas.
Feyza Engin (2009)
10.1158/1078-0432.CCR-06-1518
Preclinical In vivo Study of New Insulin-Like Growth Factor-I Receptor–Specific Inhibitor in Ewing's Sarcoma
M. Manara (2007)
10.1002/(SICI)1097-0215(20000201)85:3<430::AID-IJC21>3.0.CO;2-Q
An ovarian adenocarcinoma line derived from SV40/E‐cadherin‐transfected normal human ovarian surface epithelium
A. Ong (2000)
10.1073/pnas.0700115104
Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis
T. Schmelzle (2007)
10.1038/sj.onc.1205300
Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells
G. Fiucci (2002)
10.1091/MBC.E07-10-1092
Induction of autophagy during extracellular matrix detachment promotes cell survival.
Christopher K. H. Fung (2008)
10.1200/JCO.2003.03.006
Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized ewing tumor.
G. Schleiermacher (2003)
10.1038/sj.bjc.6604735
Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma
H. Zhang (2008)
10.1074/jbc.272.49.30822
The Insulin-like Growth Factor-I Receptor Is Required for EWS/FLI-1 Transformation of Fibroblasts*
J. Toretsky (1997)
10.1002/jcb.10465
α4 integrin increases anoikis of human osteosarcoma cells
R. Marco (2003)
10.1016/S0002-9440(10)63390-1
Adhesion-mediated squamous cell carcinoma survival through ligand-independent activation of epidermal growth factor receptor.
X. Shen (2004)
10.1083/JCB.124.4.619
Disruption of epithelial cell-matrix interactions induces apoptosis
S. Frisch (1994)
10.1038/nrc2622
Metastasis: from dissemination to organ-specific colonization
D. Nguyen (2009)
10.1016/S0092-8674(00)80486-9
Activation of Phosphoinositide 3-OH Kinase by the α6β4 Integrin Promotes Carcinoma Invasion
L. Shaw (1997)
10.1016/S0140-6736(97)02307-6
Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup
R. Souhami (1997)
10.1074/jbc.M405323200
Human Intestinal Epithelial Cell Survival and Anoikis
G. Dufour (2004)
10.1074/jbc.273.43.28065
Stat3 Plays an Important Role in Oncogenic Ros- and Insulin-like Growth Factor I Receptor-induced Anchorage-independent Growth*
C. S. Zong (1998)
10.1016/S0002-9440(10)64031-X
Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas.
K. Wiechen (2001)
10.1038/nature02765
Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB
Sirith Douma (2004)
10.1158/0008-5472.CAN-04-3135
Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma.
X. Wan (2005)
10.1016/J.EJCA.2006.03.007
PI3-K/Akt-mediated anoikis resistance of human osteosarcoma cells requires Src activation.
C. Diaz-Montero (2006)
10.1038/nm1712
Dimorphic effects of Notch signaling in bone homeostasis
Feyza Engin (2008)
10.1038/sj.cgt.7700442
Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells
K. Scotlandi (2002)
10.1126/science.7531366
Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix
N. Boudreau (1995)
10.1016/J.YEXCR.2004.02.002
Regulation of anoikis by Cdc42 and Rac1.
Tzu-Ling Cheng (2004)
10.1016/S0140-6736(96)91015-6
The war on cancer
M. Sporn (1996)
10.1083/JCB.120.1.129
Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker
M. Algrain (1993)
10.1158/1078-0432.CCR-08-1657
Inhibition of Src Phosphorylation Alters Metastatic Potential of Osteosarcoma In vitro but not In vivo
P. Hingorani (2009)
10.1126/scisignal.2000369
SIK1 Couples LKB1 to p53-Dependent Anoikis and Suppresses Metastasis
H. Cheng (2009)
10.1038/sj.onc.1205053
Anchorage-independent multi-cellular spheroids as an in vitro model of growth signaling in Ewing tumors
E. Lawlor (2002)
10.1083/jcb.200312074
Switch from αvβ5 to αvβ6 integrin expression protects squamous cell carcinomas from anoikis
S. Janes (2004)
10.1002/glia.20866
Neuregulin‐1β and neuregulin‐1α differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells
J. C. Eckert (2009)
10.1210/ER.2006-0046
Notch signaling in development and cancer.
Victoria Bolós (2007)
10.1158/0008-5472.CAN-06-3259
E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase.
Hyung-Gyoo Kang (2007)
10.1158/0008-5472.CAN-07-3148
Anoikis, initiated by Mcl-1 degradation and Bim induction, is deregulated during oncogenesis.
Nicholas T Woods (2007)
The ezrin-like family of tyrosine kinase substrates: receptor-specific pattern of tyrosine phosphorylation and relationship to malignant transformation.
F. Fazioli (1993)
Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: a possible therapeutic target.
K. Scotlandi (1996)
10.1158/1078-0432.CCR-05-0165
Hematogenous Micrometastases in Osteosarcoma Patients
Ø. Bruland (2005)
10.1016/0092-8674(92)90143-Z
Caveolin, a protein component of caveolae membrane coats
K. G. Rothberg (1992)
Adjuvant therapy in the treatment of osteosarcoma.
M. Link (1986)
10.1038/sj.onc.1204598
Biology of EWS/ETS fusions in Ewing's family tumors
A. Arvand (2001)
10.1158/0008-5472.CAN-06-4697
Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling.
L. Cantiani (2007)
10.1158/0008-5472.CAN-06-3469
Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival.
A. Shor (2007)
10.1200/JCO.2000.18.17.3108
Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group.
S. Cotterill (2000)
10.1016/j.ccr.2009.03.017
Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition.
V. Evdokimova (2009)
10.1158/1078-0432.CCR-04-2469
Circulating Tumor Cells in Breast Cancer: Correlation to Bone Marrow Micrometastases, Heterogeneous Response to Systemic Therapy and Low Proliferative Activity
V. Müller (2005)
10.1038/NG0294-146
A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS–family transcription factor, ERG
P. Sorensen (1994)



This paper is referenced by
10.3892/etm.2019.7681
(3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one inhibited osteosarcoma growth by inducing apoptosis
Mingzhu Song (2019)
10.3892/mmr.2017.6136
Interference with Tim-3 protein expression attenuates the invasion of clear cell renal cell carcinoma and aggravates anoikis
M. Yu (2017)
CHARACTERIZATION OF ERBB4 EXPRESSION IN OSTEOSARCOMA
Nupur Lala (2015)
10.3390/ijms19020615
Sarcoma Spheroids and Organoids—Promising Tools in the Era of Personalized Medicine
G. Colella (2018)
10.1016/j.ejca.2013.01.032
Ovarian tissue cryopreserved for fertility preservation from patients with Ewing or other sarcomas appear to have no tumour cell contamination.
T. Greve (2013)
10.1002/pbc.27251
Age dependency of primary tumor sites and metastases in patients with Ewing sarcoma
Jennifer Worch (2018)
10.2174/1568009611313040005
The histone deacetylase inhibitor, MS-275 (entinostat), downregulates c-FLIP, sensitizes osteosarcoma cells to FasL, and induces the regression of osteosarcoma lung metastases.
K. Rao-Bindal (2013)
10.3892/ol.2018.9696
Effects of FHIT gene on proliferation and apoptosis of osteosarcoma cells
Z. Xu (2019)
10.3892/or.2018.6827
Anoikis-resistant human osteosarcoma cells display significant angiogenesis by activating the Src kinase-mediated MAPK pathway
Z. Gao (2019)
10.1016/j.addr.2014.07.012
3D tissue-engineered model of Ewing's sarcoma.
Salah-Eddine Lamhamedi-Cherradi (2014)
10.1016/j.addr.2019.04.003
Tissue engineered models of healthy and malignant human bone marrow.
A. Chramiec (2019)
A Combination Treatment of Glycolytic Inhibitor and Reactive Oxygen Stress Enhancer in Sorafenib-resistant and High Metastatic Potential Hepatocellular Carcinoma Cells
Minjong Lee (2008)
10.1016/j.biocel.2012.11.001
Statins, autophagy and cancer metastasis.
J. Zhang (2013)
10.1186/s40425-015-0067-z
Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma
Danielle M. Lussier (2015)
10.3892/or.2017.5842
High expression of TRIM29 (ATDC) contributes to poor prognosis and tumor metastasis by inducing epithelial‑mesenchymal transition in osteosarcoma.
Si-Xiang Zeng (2017)
Development of a High-Throughput 3D Tumor Model for Bone Sarcomas
M. Santoro (2016)
10.18632/oncotarget.13160
CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling
M. Manara (2016)
10.1080/07357907.2019.1698592
Inhibitory Effects of Indomethacin in Human MNNG/HOS Osteosarcoma Cell Line In Vitro
S. Mirshahidi (2019)
Cellular mechanisms of organ-specific metastasis of Ewing's sarcoma
Henrike K. Knizia (2011)
CD 99 triggering induces methuosis of Ewing sarcoma cells through IGF-1 R / RAS / Rac 1 signaling
M. Manara (2018)
10.1016/j.jbo.2017.10.002
Inhibition of IL-18-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy against osteosarcoma cancer
Y. Guan (2017)
10.7314/APJCP.2014.15.19.8203
Correlation between E-cadherin-regulated cell adhesion and human osteosarcoma MG-63 cell anoikis.
D. Lin (2014)
10.1007/s13277-016-5401-7
Overexpression of pyruvate kinase M2 predicts a poor prognosis for patients with osteosarcoma
Zheng-xuan Liu (2016)
10.2147/CBF.S40803
Biomarkers in the Ewing sarcoma family of tumors
I. Machado (2014)
10.1016/j.prp.2017.06.004
High expression levels of Cyr61 and VEGF are associated with poor prognosis in osteosarcoma.
Y. Liu (2017)
10.1080/10717544.2018.1497105
Local release of gemcitabine via in situ UV-crosslinked lipid-strengthened hydrogel for inhibiting osteosarcoma
W. Wu (2018)
The expression of FHIT messenger ribonucleic acid (mRNA) was detected by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). The expression of FHIT protein was detected by western blot analysis. Cell Counting Kit 8 (CCK8)
Xu Zheng-feng (2018)
10.1016/j.canlet.2017.10.012
MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma.
Xiu-tao Fu (2018)
10.1371/journal.pone.0174271
3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells
Minjong Lee (2017)
10.1186/1471-2407-14-169
Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing’s sarcoma via inhibition of cell migration
G. Odri (2013)
10.2217/fon.13.183
Safety considerations for transplanting cryopreserved ovarian tissue to restore fertility in female patients who have recovered from Ewing's sarcoma.
S. D. Sørensen (2014)
10.1038/s41419-019-1532-2
Anoikis resistant mediated by FASN promoted growth and metastasis of osteosarcoma
T. Sun (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar